BamSEC and AlphaSense Join Forces
Learn More

Viracta Therapeutics Inc.

NASDAQ: VIRX    
Share price (12/23/24): $0.23    
Market cap (12/23/24): $9.248 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1
from SC 13G/A ~1 page Joint Filing Statement Statement Pursuant to Rule 13d-1
12/34/56
EX-1.1
from 8-K 41 pages 52,173,913 Shares Sunesis Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1
12/34/56
EX-1
from SC 13G 2 pages Joint Filing Statement Pursuant to Rule 13d-1
12/34/56
EX-1.2
from 8-K 41 pages 8,333 Shares Sunesis Pharmaceuticals, Inc. Series F Convertible Preferred Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages 33,333,667 Shares Sunesis Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.2
from 8-K 40 pages 17,000 Shares Sunesis Pharmaceuticals, Inc. Series E Convertible Preferred Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages 23,000,000 Shares Sunesis Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.2
from 8-K 42 pages 2,500 Shares of Series D Convertible Preferred Stock Warrants to Purchase 1,250,000 Shares of Common Stock Sunesis Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages 7,500,000 Shares Warrants to Purchase 3,750,000 Shares Sunesis Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13G 1 page Joint Filing Agreement
12/34/56
EX-1.2
from 8-K 41 pages 1,558 Shares Sunesis Pharmaceuticals, Inc. Series C Convertible Preferred Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages 4,935,500 Shares Sunesis Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.2
from 8-K 40 pages 20,200 Shares Sunesis Pharmaceuticals, Inc. Series B Convertible Preferred Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 39 pages 9,561,905 Shares Sunesis Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 43 pages 4,650,000 Shares Series a Warrants to Purchase 4,650,000 Shares Series B Warrants to Purchase 4,650,000 Shares Sunesis Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 63 pages 44,145,706 Shares Warrants to Purchase 22,072,853 Shares Sunesis Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 34 pages 4,750,000 Shares Sunesis Pharmaceuticals, Inc. Common Stock, $0.0001 Par Value Per Share Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 38 pages Shares Sunesis Pharmaceuticals, Inc. Common Stock $0.0001 Par Value
12/34/56